The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 25, Issue 9, Pages 1502-1509
Publisher
Springer Nature
Online
2011-05-24
DOI
10.1038/leu.2011.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Unmobilized and Mobilized Graft Characteristics and the Implications of Cell Subsets on Autologous and Allogeneic Transplantation Outcomes
- (2010) Stefan Fruehauf et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo
- (2010) M. Seiffert et al. BLOOD
- Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
- (2010) Marita Ziepert et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?
- (2010) N. George Mikhaeel LEUKEMIA & LYMPHOMA
- Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas – the PETAL trial
- (2010) Ulrich Dührsen et al. LEUKEMIA & LYMPHOMA
- Cancer-Associated Myeloproliferation: Old Association, New Therapeutic Target
- (2010) Ryan A. Wilcox MAYO CLINIC PROCEEDINGS
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
- Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy
- (2009) M.-K. Song et al. ANNALS OF ONCOLOGY
- New-Onset Lymphopenia Assessed during Routine Follow-up Is a Risk Factor for Relapse Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma
- (2009) Luis F. Porrata et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
- (2009) R. A. Wilcox et al. BLOOD
- B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
- (2009) R. A. Wilcox et al. BLOOD
- Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
- (2009) Heidi Nyman et al. MODERN PATHOLOGY
- Myeloid-derived suppressor cells: A novel therapeutic target
- (2009) Jennifer S. Ko et al. Current Oncology Reports
- Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma
- (2008) M. Christina Cox et al. BRITISH JOURNAL OF HAEMATOLOGY
- Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients’ survival benefit from rituximab
- (2008) Yasuhiro Oki et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
- (2008) A. Tzankov et al. HAEMATOLOGICA
- Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis
- (2008) Na-Ri Lee et al. LEUKEMIA & LYMPHOMA
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started